title: Type 1 diabetes caused by interferon alpha-2alpha in polycythemia vera therapy.
authors.forename: Xian-Ling
authors.initials: XL
authors.lastname: Wang
authors.forename: Yi-Ming
authors.initials: YM
authors.lastname: Mu
authors.forename: Zhao-Hui
authors.initials: ZH
authors.lastname: Lu
authors.forename: Ju-Ming
authors.initials: JM
authors.lastname: Lu
authors.forename: Jing-Tao
authors.initials: JT
authors.lastname: Dou
authors.forename: Chang-Yu
authors.initials: CY
authors.lastname: Pan
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha